Innovation meets cardiovascular trial expertise.
Cardiovascular clinical trials, no matter their size, demand a specialized, experienced cardiovascular CRO to help you navigate the path to success.
With unmatched cardiovascular trial experience and new approaches fueled by data and analytics, IQVIA brings agility and speed to trials large and small.
100%
of the top 20 cardiovascular drugs in 2019 were developed with help from IQVIA
New options for your cardiovascular trials
- Data and analytics for adaptive and novel trial approaches
- Innovative patient-centered trials using virtual and hybrid models
- Transformative technologies to identify the “right” sites and accelerate enrollment
- Proven track record and global leadership in patient retention and preventing LTFU
- Industry leading AI/ML driven technologies for Risk Based Monitoring
Cardiovascular research powered by the IQVIA CORE™
- Reduce patient burden with Virtual and Hybrid trial solutions
- Model and predict event rates with the world’s largest healthcare data source
- Optimize study protocols by refining eligibility criteria and schedule of assessments
- Create Direct-to-patient multi-channel recruitment campaigns for rare and common disease populations
- Enable patient-centered recruitment and tailored site strategies through new technology solutions
- Monitor safety and efficacy endpoints in near real time with wearables and connected devices
Virtual Approaches for Cardiovascular Trials
Challenges of cardiovascular development
- Pressure to bring down the time and cost of cardiovascular trials
- Need for fast site activation and recruitment of extremely large patient populations globally
- Retention of patients to prevent lost to follow-up (LTFU) over the length of the study
- Analysis of vast amounts of data quickly to detect safety signals and endpoint information
Change the model of clinical research by integrating data, expertise, analytics and technology from study design through execution to power better decisions.
Flexible solutions. Responsive teams. Data-driven insights.
Access new resources for advanced therapy development, from candidate identification through market authorization.